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Facilitated techniqueAbstract Objectives: Ambu aScop2 (aScope2) is a new disposable ﬂexible videoscope, that has
several advantages compared with the reusable devices. The purpose of this study was to evaluate
the efﬁcacy of this device in awake nasotracheal intubation for patients with anticipated difﬁcult
airway and to compare the use of facilitated technique with the conventional technique in an
attempt to fasten the nasotracheal intubation and to increase the likelihood of success.
Methods: Fifty adult patients aged 18–45 years of ASA I–III with anticipated difﬁcult intubation
were randomly allocated into two groups of awake nasotracheal intubation either by the conven-
tional technique of videoscopic nasotracheal intubation (C group) or by facilitated technique (F
group) where a lubricated nasal tube was introduced ﬁrst into nasopharynx till the mark 18 in males
and 16 in females acting as a conduit for the aScope, then the aScope 2 was inserted through it to
visualize the vocal cords and then advanced into the trachea, ﬁnally the nasal tube railroaded over
the aScope. Times needed to visualize vocal cords (Tvc), to complete the endotracheal intubation
(Tti) and the sum of both were recorded. Also number of attempts, the need of facilitating maneu-
ver, success rate and any complications were compared.
Results: The overall success rate of aScope-guided intubation was 84% and 92% in the control and
the facilitated groups respectively with a higher 1st attempt success rate in the facilitated group.
Both Tvc and total nasotracheal intubation time were signiﬁcantly shorter in facilitated group
(156 ± 0.81 and 198.6 ± 0.82 s) compared to (201.6 ± 1.15 and 244.8 ± 1.15 s) in control group.
Conclusion: The aScope 2 provided a high success rate in awake nasotracheal intubation in patients
with anticipated difﬁcult airway and the use of a facilitated technique shortened the time needed to
perform successful videoscopic intubation.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Difﬁcult intubations contribute to considerable morbidity and
mortality in anesthesia [1]. Complications of difﬁcult airways
range from upper airway soft tissue trauma to hypoxic brain
damage and death [2].
Nasotracheal ﬁberoptic intubation is the best option and is
often the gold standard where oral route is impossible. It has
certain advantages such as the route to larynx is easier than
mouth and also the patient is unable to bite the scope [3].
The nasal route provides an easier view of the laryngeal open-
ing as a result of decreased interference from the tongue. In
addition, the gag reﬂex is less pronounced with nasal intuba-
tion than with oral intubation [4]. The conventional ﬁber-
optic nasal intubation method in which the nasal tube is
inserted in one step after visualization of the vocal cords by
a ﬂexible ﬁber-optic laryngoscope [5], two major problems
are encountered, i.e. visualization of the glottis and the entry
point at the level of vocal cords, and insertion of the ﬁberscope
into the trachea [5,6]. Placing a lubricated endotracheal tube
through the nostril can guide the ﬁberoptic scope toward the
larynx. It would be helpful for optimal visualization of the
vocal cords when the scope is passed through the endotracheal
tube if the length of nares-vocal cord (NV length) could be pre-
dicted and the tip of the endotracheal tube could be placed
close to the vocal cord [7].
Although ﬁberoptic scopes are well established in the man-
agement of difﬁcult airways [8], these reusable devices need to
be disinfected before each use. This cleaning process can take
20–60 min to complete [9]. In addition, some contamination
may remain despite cleaning [10].
The Ambu aScope (Ambu A/S, Ballerup, Denmark) is a
novel single-use video-endoscope designed to aid tracheal intu-
bation. According to the manufacturer, it is designed with an
outer diameter of 5.3 mm and a bending section that can be
manipulated through an angle of 120 upwards and downward.
The aScope has a built-in camera with a light-emitting diode
(LED) and a channel with an inner diameter of 0.8 mm for
administering local anesthetic. Before use, the scope has to
be connected to a separate 6.5-inch color liquid crystal display
(LCD) monitor [11]. It has several possible advantages: no
requirement for cleaning or disinfection, no repair costs,
avoidance of the small, but existing, risk of cross contamina-
tion and the possibility of always having access to a ﬂexible
scope, which is not the case with reusable scopes [12]. The
aScope successfully had been used to facilitate tracheal intuba-
tion with anticipated or unanticipated difﬁcult airways [11].
The purpose of this study was to evaluate this novel video-
scope in nasotracheal intubation in anticipated difﬁcult air-
ways where oral route is impossible, through using the
conventional method or a facilitated one by placing a lubri-
cated endotracheal tube through the nostril that can guide
the videoscope towards the larynx.
2. Methodology
After approval of institutional ethics committee of Faculty of
Medicine, Minia University and a small pilot study performed
on 10 patients with normal airway for initial evaluation of the
device and to predict the nares to vocal cord distance in
either sex, this prospective, randomized, parallel study wasconducted in the period from June 2013 till December 2014,
on ﬁfty patients, aged 18–45 yrs of both sex, ASA physical
status I–III underwent elective maxillofacial surgery under
general anesthesia with an anticipated difﬁcult airway
requiring nasotracheal intubation as the oral route was impos-
sible. The patients were randomly allocated into two groups by
using a computer-generated table and the randomization
sequence was concealed in sealed envelopes assignment held
by an assistance who not involved with the clinical manage-
ment or data collection. According to the method of nasal
intubation used, the two groups were either, a conventional
group (control) or facilitated group of 25 patients in each with
an allocation ratio of 1:1. We explained the procedure during
the pre-operative visit and all the included patients gave their
consent for awake videoscopic intubation. Exclusion was for
those with any contraindication for nasal intubation, bleeding
disorder, reactive airway disease and gastroesophageal reﬂux
(see Fig. 1). Pre-operative airway evaluation was performed
in terms of the previous history of difﬁcult intubation;
pathologies and symptoms associated with difﬁcult intubation;
inter-incisor gap and mandible movement; thyromental
distance; head and neck movement; and the modiﬁed
Mallampati score Table 1.
Pathologies associated with the difﬁcult intubation varied
between intra-oral tumor, ankylosis of temporomandibular
joint or burn with neck contracture and limited mouth open-
ing. Patient age, weight, height and body mass index were
recorded. All patients fasted for at least 6 h before surgery.
Each patient received 500 mL of Ringer’s solution IV 1 h
before surgery.
In the operative room, routine monitoring with ECG, non-
invasive blood pressure, pulse oximetry and capnography com-
menced. These vital parameters were recorded at baseline, and
every 5 min thereafter, then a cannula was sited and all
patients were premedicated with metoclopramide 10 mg IV,
midazolam 0.05 mg/kg IV, atropine 0.5 mg IV to reduce the
secretions of airways and phenylephrine drops (3 drops in each
nostril) 15 min before airway manipulation. Topical anesthesia
was achieved by nebulizer for 10 min using 10 ml lidocaine
2%. The larger nostril was selected for intubation while
through the other nostril a nasal cannula was inserted to
administer 100% oxygen (2 L/min) was started 3 min before
and then along the procedure. A fentanyl bolus of 1 lg/kg
and propofol infusion at the rate of 30–35 lg/kg/min. were
administered before manipulation.
With the patients in supine position, intubation was per-
formed by the same anesthetist with help of three attendants
one for suctioning and oxygenation, another for administering
local anesthetic through the channel of the videoscope and the
intravenous drugs, and the third for monitoring the patients
and recording the data.
In the conventional group, the cord of the aScope was
inserted through the nostril and advanced into the nasophar-
ynx till the vocal cords were visualized. Then, a lubricated
nasal tube, which had been mounted and ﬁtted on the scope
beforehand, was glided over the videoscope and advanced
through the vocal cords into the trachea. Whereas in the facil-
itated group, or the tube-ﬁrst approach, the lubricated nasal
tube was inserted into the nasal cavity and advanced through
it into the nasopharynx till the mark 18 in men and 16 in
women reached the level of alae of the nose. At this level,
the tube tip is nearly placed just above the larynx, then the
Assessed for eligibility (n=62)
Excluded  (n=10)
♦ Not meeting inclusion criteria (n=6) 
♦ Declined to participate (n=3) 
♦ Other reasons (n=1) 
Analysed  (n= 25)
♦ Excluded from analysis (give reasons) (n=0)
Lost to follow-up (give reasons) (n= 0)
Discontinued intervention (give reasons) (n=0)  
Allocated to intervention (n=26)
♦ Received allocated intervention (n= 25)
♦ Did not receive allocated intervention (give 
reasons) (n=1) surgical problem
Lost to follow-up (give reasons) (n= 0 )
Discontinued intervention (give reasons) (n=0)
Allocated to intervention (n=26)
♦ Received allocated intervention (n=25)
♦ Did not receive allocated intervention (give 
reasons) (n=1) uncooperative patient 
Analysed  (n=25)
♦ Excluded from analysis (give reasons) (n=0) 
Allocation
Analysis
Follow-Up
Randomized (n=52)
Enrollment
Figure 1 Participant ﬂow diagram.
Table 1 Modiﬁed Mallampati score grading of the upper
airway (Samsoon and Young) [13].
 Class I: everything visible (tonsillar pillars)
 Class II: uvula fully visible, fauces visible
 Class III: soft palate and base of uvula visible only
 Class IV: cannot see soft palate
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passed the tip of it to visualize the larynx, and then inserted
between the cords toward the trachea followed by sliding the
tube over the cord into the trachea. Repositioning of the tube
to optimize visualization and suctioning with an oral catheter
were needed in some cases.
After successful passage of the tube through the vocal cords
into the trachea and after identiﬁcation of the carina, the tube
was positioned approximately 3 cm above the carina which
corresponds to the mark of 26–28 cm at the nares, then the
scope was withdrawn and the cuff of the tube was inﬂated
and the tube was sealed with adhesive tape.
Correct placement of the tube was conﬁrmed by the end-
expiratory CO2 curve on capnography and by bilateral auscul-
tation. Immediately propofol 1–2 mg/kg IV was administered
to induce general anesthesia and to establish mechanical
ventilation. During the procedure, patients were awake andmost of them were co-operative with the anesthetist. If it was
necessary, facilitating techniques such as head ﬂexion, and
jaw thrust were utilized.
2.1. Parameters assessed
In addition to the parameters of assessment mentioned above
(mouth opening, Mallampati class, neck movement, thyromen-
tal distance, and prognathism ability), the following data were
recorded:
1. Primary outcomes:
a. The time from the start of insertion of the aScope in the
nares till visualization of vocal cords (Tvc) and from
this till successful endotracheal intubation and cuff
inﬂation (Tti), then the total time of nasotracheal intu-
bation which is the sum of the previous two times were
recorded in seconds.b. success rate
2. Secondary outcomes:
The number of attempts, the need of facilitating maneuvers,
the incidence of esophageal intubation or any complica-
tions were recorded.
Intubation was considered failed if desaturation
(SpO2 < 95%) occurred before identiﬁcation of the carina in
spite of the precautions taken to provide oxygen.
Table 3 Airway Assessment in the studied groups (data
expressed as number and percentage).
Variable Group C
(n= 25)
Group F
(n= 25)
P
value
Mallampati class:
Class III 8 (32%) 7 (28%) 0.758
Class IV 17 (68%) 18 (72%)
Mouth opening:
>4 cm 8 (32%) 7 (28%) 0.758
<4 cm 17 (68%) 18 (72%)
Neck movement: 1
90 10 (40%) 10 (40%)
80–90 9 (36%) 9 (36%)
<80 6 (24%) 6 (24%)
Thyromental
distance:
>6.5 10 (40%) 10 (40%) 0.931
6–6.5 9 (36%) 10 (40%)
<6 6 (24%) 5 (20%)
Prognathism
ability:
Yes 19 (76%) 18 (72%) 0.747
No 6 (24%) 7 (28%)
Table 4 Times of nasotracheal intubation (data expressed as
mean ± SD).
Variable GC
(n= 25)
GF
(n= 25)
P
value
Time to VC visualization (s) (60–300) (60–240) 0.010*
201.6 ± 1.15 156 ± 0.81
Time to Ti (s) (30–54) (30–54) 0.802
43.2 ± 0.1 42.6 ± 0.12
Total time of nasotrach. (s) (108–348) (90–288) 0.010*
244.8 ± 1.15 198.6 ± 0.82
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The collected data were coded, tabulated, and statistically ana-
lyzed using SPSS program (Statistical Package for Social
Sciences) software version 20.
Descriptive statistics were done for numerical data by
mean, standard deviation and minimum and maximum of
the range, while they were done for categorical data by number
and percentage.
– Analyses were done for quantitative variables using inde-
pendent sample t test, and for qualitative variables using
Chi square test.
– The level of signiﬁcance was taken at P-value 6 0.05.
The sample size was based on an initial pilot observation
and previous studies, in order to ensure a power of 0.80 for
detecting clinically meaningful difference in intubation time
with a type-1 error of 0.05. Assuming a 5% dropout rate, 25
patients in each group were studied with an allocation ratio 1.
4. Results
Statistical analysis showed there were no signiﬁcant differences
between the two groups regarding age, sex, weight, height,
body mass index (BMI) and ASA class as well as the parame-
ters of the airway assessment (Tables 2 and 3).
As shown in (Table 4) the time to vocal cord visualization
(Tvc) as well as the total time of nasotracheal intubation was
signiﬁcantly shorter in the facilitated group than in the control
group, however there was no signiﬁcant difference between the
two groups regarding the time of tracheal intubation (Ti).
The overall success rate of aScope-guided intubation was
84% and 92% in the control and the facilitated groups respec-
tively but it was statistically insigniﬁcant. Nasotracheal intuba-
tion achieved at the ﬁrst attempt in 48% and 84% of cases, at
2nd attempt in 24% and 8% and at the 3rd attempt in 28%Table 2 Demographic Proﬁle of the studied groups (data
expressed as Mean ± SD or number and percentage).
Variable Group C (n= 25) Group F (n= 25) P value
Age (18–45) (18–43) 0.220
31.84 ± 8.39 28.96 ± 7.99
Sex:
Female 14 (56%) 13 (52%) 0.777
Male 11 (44%) 12 (48%)
Weight (58–88) (55–90) 0.148
74.4 ± 10.49 70.32 ± 9.07
Height (150–172) (145–178) 0.752
164 ± 9.27 164.88 ± 10.26
BMI (19–41) (20–39) 0.305
27.6 ± 4.97 26.16 ± 4.85
ASA:
Class I 13 (52%) 13 (52%) 1
Class II 10 (40%) 10 (40%)
Class III 2 (8%) 2 (8%)
No signiﬁcance difference p-value > 0.05.
BMI = Body Mass Index.
Time to vc = time to vocal cord visualization
Time to Tti = time to tracheal intubation.
Total time of nasotrach.= Total time of nasotracheal intubation.
* Signiﬁcant difference p-value 6 0.05.and 8% of cases in the control and facilitated groups respec-
tively with a signiﬁcant difference in favor of the facilitated
group (Table 5).
Also the need for jaw thrust and neck ﬂexion was signiﬁ-
cantly more often in the conventional group (20% and 30%
respectively) in comparison with the facilitated group (12%
and 8% respectively). The incidence of esophageal intubation
(P-value 0.637) or any complication in terms of bleeding or
desaturation (P-value 0.919) was insigniﬁcant between the
two groups (Table 5).
5. Discussion
In this study, the use of aScope 2 provided a high success rate
in awake nasotracheal intubation in patients with anticipated
difﬁcult airway and the use of a facilitated technique shortened
the time needed to perform this videoscopic nasotracheal
Table 5 No. of attempts, the need of facilitating maneuver,
success rating, incidence of esophageal intubation or compli-
cations in the studied groups (data expressed as number and
percentage).
Variable Group C
(n= 25)
Group F
(n= 25)
P
value
No of attempts:
1 time 12 (48%) 21 (84%) 0.027*
2 times 6 (24%) 2 (8%)
3 times 7 (28%) 2 (8%)
Facilitating manoveur:
No 12 (48%) 20 (80%) 0.047*
Jaw thrust 5 (20%) 3 (12%)
Neck ﬂexion 8 (32%) 2 (8%)
Success rating:
Failed 4 (16%) 2 (8%) 0.384
Success 21 (84%) 23 (92%)
Esophageal intubation:
No 22 (88%) 23 (92%) 0.637
Yes 3 (12%) 2 (8%)
Complications:
No 20 (80%) 19 (76%) 0.919
Bleeding 3 (12%) 4 (16%)
Desaturation 2 (8%) 2 (8%)
* Signiﬁcant difference p-value 6 0.05.
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conventional technique.
The evolving technology of miniature digital cameras has
led to ﬂexible optics without typical ﬁberoptic bundle technol-
ogy. These videoscopes have to be connected to a separate
monitor to generate a picture. The Ambu aScope is a novel
single-use video-endoscope designed to aid tracheal intubation
[11]. The availability of this disposable ﬂexible optical scope
has several possible advantages for the anesthesiologist: No
cumbersome cleaning, no repair costs, avoidance of the small,
but existing, risk of cross-contamination [14] and the possibil-
ity of always having access to a ﬂexible scope, which is not the
case with the expensive reusable scopes [15].
However, it is mandatory to evaluate the clinical perfor-
mance of a disposable ﬂexible scope to make sure of its efﬁ-
ciency in managing patients presenting with severely difﬁcult
airways. Some studied had performed in simulated difﬁcult
intubation in a manikin and others are limited to some case
reports [11,12,16] and they found that it was successfully used
for awake intubation in patients with difﬁcult airways and
seems to offer a valuable supplement, or maybe even alterna-
tive, to the existing reusable ﬂexible ﬁberoptic and recom-
mended further evaluation. As a very limited published
evidence regarding the value of the aScope in nasotracheal
intubation in anticipated difﬁcult airway as the oral route is
impossible, this study conducted on ﬁfty patients where awake
nasotracheal intubation performed using two techniques, the
conventional method and a facilitated method in which a
lubricated nasal tube was placed ﬁrstly into the nasopharynx
till the mark 18 in males and 16 in females reached the level
of alae of the nose. The detection of nares to vocal cord dis-
tance depended on our pilot study and the revision of the pre-
vious studies.Han et al., 2005 estimated the nasal to vocal cord length of
the males was 18.3 ± 0.8 cm, and that of the females was
16.3 ± 0.7.
Techanivate and his colleagues [17] in a study to predict the
proper depth of placement of endotracheal tubes, oral and
nasal estimated the distance from the right external naris to
the vocal cords distance to be 15.00 ± 0.84 cm with no rela-
tion to the gender.
Also the study conducted by Mohammadzadeh et al. [18]
on patients allocated for elective maxillofacial operation of
miniplate insertion in the upper and lower jaws with ﬁber-
scopic nasal intubation using either the conventional method
or NASAL-18 technique where they insert the nasal tube to
a ﬁxed mark of 18 at the alae irrespective of the gender.
The major reason for difﬁculty in advancing an endotra-
cheal tube over a ﬁberscope is considered to be deviation of
the course of the tube from that of the ﬁberscope (because of
the gap between the two) toward the epiglottis, arytenoid car-
tilage, pyriform fossae, or esophagus [19,20]. Another con-
tributing factor in difﬁcult exposures was decreased space
between the edge of the epiglottis and posterior pharyngeal
wall [19].
In the current research, the aScope had achieved a good
success rate (84% in conventional group and 92% in facilitated
group) in awake nasotracheal intubation for patients with dif-
ﬁcult and sometimes extremely difﬁcult airway. Also the han-
dling of the aScope and its transportation were easy due its
light weight and the image of the airway structures was consid-
erably good. This is consistent with the ﬁndings of Kristensen
and Fredensborg [21] where 40 patients with predicted difﬁcult
tracheal intubation were randomly assigned to be intubated
awake with either the aScope or the reusable Olympus video-
bronchoscope. They concluded that both aScope and
Olympus videoscope allowed safe awake intubation in those
elective patients with difﬁcult, but uncompromised, airways.
Also Scutt et al. [22] who compared the Ambu aScope with
a conventional ﬁbrescope in three airway training manikins
for oral intubation, nasal intubation and intubation via three
supraglottic airway devices concluded that the performance
of the aScope was good with few failures and infrequent prob-
lems in simulated ﬁberoptic intubation and (if adapted for
untimed use) would be a useful training tool for both simu-
lated ﬁberoptic intubation and conduit-assisted intubation
but as manikin study does not predict the performance in
humans they recommended clinical studies. On the other hand,
Krugel and his colleagues [23] in comparing the second gener-
ation single-use Ambu() aScope 2 videoscope with a stan-
dard re-usable ﬂexible ﬁbrescope in 50 patients with a
difﬁcult airway simulated by a semirigid collar, although all
the patients were intubated successfully with the aScope 2 or
the re-usable ﬁberscope, they do not support the use of the
single-use aScope 2 videoscope as an alternative to the re-
usable ﬁberscope due to longer time and poorer scores for
quality of vision.
In our study, the insertion of lubricated ﬂexible tube ﬁrstly
in the facilitated group used as a conduit that guided the
aScope 2 through the nasal cavity toward the vocal cords
and reduced the probability of the aScope twisting with the
accompanying traumatization of the upper airway which
improved the overall success rate of intubation in this group
than the other even though the difference was not statistically
signiﬁcant. This may explain the signiﬁcant shorter time to
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time of nasotracheal intubation in the facilitated group.
Also the tube placement at the ﬁrst attempt was signiﬁ-
cantly more successful in the facilitated group (84%) than in
the conventional group (48%) and the need for using Jaw
thrust or neck ﬂexion was signiﬁcantly lower (20%).
Our results agree with those of Mohammadzadeh et al. [18]
whom found that NASAL-18 method reduces the time needed
for successful ﬁberoptic intubation with higher success rate
with the NASAL-18 method (83.3%), while this rate in the
conventional method was at 67%, with an emphasis on the
aScope 2 not the ﬁberscope was used in our research and all
the studied cases had difﬁcult or extremely difﬁcult airway, still
the success rate was higher in our study.
It is obvious that the use of a facilitating technique allows
the anesthetist to perform ﬁberscopy with greater ease and
speed. Scutt et al. [22] in their study mentioned before con-
cluded that, the intubation times were faster when using a con-
duit than without and the type of ﬁberscope had no
statistically signiﬁcant effect on intubation speed, but the type
of conduit had, thus, the intubation via the i-gel was 12 s faster
than the cLMA (31 s) and 5 s faster than the ILMA (24 s).
Hughes and Smith [24] assessed the effectiveness of three tra-
cheal tube rotational movements in assisting nasotracheal tube
placement over the ﬁberoptic laryngoscope and recommended
that 90 degrees anticlockwise or overcorrected 90 degrees anti-
clockwise tube rotation is used to facilitate nasotracheal tube
placement during ﬁberoptic intubation.
Relative long mean time of nasotracheal insertion in this
research may be attributed to the clinical condition of some
patients as ASA class III was included in this study where cau-
tious and gentle manipulation was a must as that in a case of
severe hyperparathyroidism where pathological fractures were
present in most parts of the body including the mandible
together with cardiac problems, another explanation, some
burn patients with limited mouth opening and neck contrac-
ture were not fully cooperative due to the psychic state of those
patients, also about 10 patients had recurrent ankylosis with
redundant soft palate and some were suffering from obstruc-
tive sleep apnea. Due to lack of a large suction port in the
aScope 2, frequent suction was needed to clear the secretions
which can cause fogging of the camera, this together with lim-
ited angulation of the tip of the device were other cumbersome
causes with more time consumed.
Krugel et al. [23], explained the longer intubation times
with the aScope 2 in their study essentially due to a lesser range
of movement of the tip, with a limited angulation (120 up and
down, whereas the standard ﬁbrescopes presents a tip mobility
of 180 up and 130 down) which makes it difﬁcult to pass
under the tongue or a falling epiglottis.
This research has some limitations, ﬁrst the aScope was not
compared to the standard ﬁberscope to clarify the performance
of each, second, all of the intubations were performed by the
same anesthetist, if different experiences provided the intuba-
tion and the rate of success and the times involved might be
different. Lastly we did not evaluate the efﬁciency of the device
in the unanticipated difﬁcult airway.
In conclusion, the aScope 2 provided a high success rate in
awake nasotracheal intubation in patients with anticipated dif-
ﬁcult airway and the use of a facilitated technique shortened
the time to visualize the vocal and the total time ofnasotracheal intubation with less need of facilitating maneu-
vers and higher 1st attempt success.
Since outer diameter of the aScope-2 (5.3 mm) is larger
than that of adult reusable ﬁber-optic scopes (3.5–4.2 mm), we
could not deal with some cases that required smaller tube size,
so we recommend manufacturing aScope with different cord
sizes.
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